Stay updated on Adagrasib with Palbociclib in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Adagrasib with Palbociclib in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Adagrasib with Palbociclib in Advanced Solid Tumors Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedNew revision entry v3.3.4 added to the Record History and previous revision v3.3.3 removed from the history.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedRevision: v3.3.3 was added to the history, and HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the page footer. This pertains to site-wide wording and historical metadata rather than the trial data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check57 days agoChange DetectedThe Study Record History adds Revision v3.3.2 and removes Revision v3.2.0.SummaryDifference0.1%

- Check64 days agoChange DetectedA government funding/operating status notice banner was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check86 days agoChange DetectedRecruitment status updated on 2025-02-07 for NCT05178888 (Adagrasib in Combination With Palbociclib in Patients With Advanced Solid Tumors).SummaryDifference0.1%

- Check107 days agoChange DetectedAdded a prominent government funding notice and a current operating status note, plus a version update to v3.2.0; removed the previous v3.1.0 revision tag.SummaryDifference12%

Stay in the know with updates to Adagrasib with Palbociclib in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib with Palbociclib in Advanced Solid Tumors Clinical Trial page.